Skip to main content

Ezetimibe (International)

In the US, Ezetimibe (ezetimibe systemic) is a member of the drug class cholesterol absorption inhibitors and is used to treat High Cholesterol, High Cholesterol - Familial Heterozygous and Sitosterolemia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AX09

CAS registry number (Chemical Abstracts Service)

0163222-33-1

Chemical Formula

C24-H21-F2-N-O3

Molecular Weight

409

Therapeutic Category

Lipid lowering: Cholesterol absorption inhibitor

Chemical Names

[3R,4S]-1-[p-Fluorophenyl]-3-[[3S]-3-[p-fluorophenyl]-3-hydroxypropyl]-4-[p-hydroxyphenyl]-2-azetidinone (WHO)

2-Azetidinone, 1-[4-fluorophenyl]-3-[3-[4-fluorophenyl]-3-hydroxypropyl]-4-[4-hydroxyphenyl]-, [3R-[3[S*],4]]- (USAN)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs